SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001358403-18-000026
Filing Date
2018-02-22
Accepted
2018-02-22 16:03:53
Documents
3
Period of Report
2018-02-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_151933341823774.html 3  
1 FORM 3 wf-form3_151933341823774.xml 3 1763
2 POA EDMUND HARRIGAN edharriganpoa001.jpg GRAPHIC 222554
3 POA EDMUND HARRIGAN edharriganpoa.htm EX-24 621
  Complete submission text file 0001358403-18-000026.txt   310399
Mailing Address
Business Address
HARRIGAN EDMUND (Reporting) CIK: 0001177917 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36783 | Film No.: 18632506

Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations